GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption

Journal of Applied Toxicology

Volumn 28, Issue 4, 2008, Pages 466-474

  Watcharasit, Piyajit ^a   Thiantanawat, Apinya ^a   Satayavivad, Jutamaad ^a,b  

^a Chulabhorn Research Institute   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Apoptosis; Arsenite; Bax; GSK3; Mitochondria translocation; p53

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ARSENIC TRIOXIDE; CASPASE 3; CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL DISRUPTION; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROBLASTOMA CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

APOPTOSIS; ARSENITES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; LITHIUM COMPOUNDS; MALEIMIDES; MITOCHONDRIA; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 44149124047     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1296     Document Type: Article

References (34)

1. Alessi DR, Cohen P. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8: 55-62.
2. Arima Y, Nitta M, Kuninaka S, Zhang D, Fujiwara T, Taya Y, Nakao M, Saya H. 2005. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J. Biol. Chem. 280: 19166-19176.
3. Bachleitner-Hofmann T, Kees M, Gisslinger H. 2002. Arsenic trioxide: acute promyelocytic leukemia and beyond. Leuk. Lymphoma 43: 1535-1540.
4. Bijur GN, De Sarno P, Jope RS. 2000. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 275: 7583-7590.
5. Bustamante J, Nutt L, Orrenius S, Gogvadze V. 2005. Arsenic stimulates release of cytochrome C from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol. Appl. Pharmacol. 207: 110-116.
6. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7: 793-803.
7. De Sarno P, Li X, Jope RS. 2002. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43: 1158-1164.
8. Frame S, Cohen P. 2001. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359: 11-16.
9. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65: 391-426.
10. 3)-induced apoptosis in human glioblastoma cells. Cancer Sci. 96: 825-833.
11. Hossain K, Akhand AA, Kawamoto Y, Du J, Takeda K, Wu J, Yoshihara M, Tsuboi H, Kato M, Suzuki H, Nakashima I. 2003. Caspase activation is accelerated by the inhibition of arsenite-induced, membrane rafts-dependent Akt activation. Free Radic. Biol. Med. 34: 598-606.
12. Jope RS. 1999. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4: 117-128.
13. Jope RS, Johnson GV. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29: 95-102.
14. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. 2003. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63: 2103-2108.
15. Karlsson J, Ora I, Porn-Ares I, Pahlman S. 2004. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clin. Cancer Res. 10: 3179-3188.
16. Kim AJ, Shi Y, Austin RC, Werstuck GH. 2005. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell Sci. 118: 89-99.
17. King TD, Bijur GN, Jope RS. 2001. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res. 919: 106-114.
18. Klein PS, Melton DA. 1996. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93: 8455-8459.
19. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G. 1999. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res. 249: 413-421.
20. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA. 2004. Glycogen synthase kinase-3β phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 24: 9993-10002.
21. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. 2003. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11: 577-590.
22. Mikhailov V, Mikhailova M, Degenherdt K, Venkatachalam MA, White E, Saikumar P. 2003. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome C release. J. Biol. Chem. 278: 5367-5376.
23. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. 2002. Mechanisms of action of arsenic trioxide. Cancer Res. 62: 3893-3903.
24. Moll UM, Wolff S, Speidel D, Deppert W. 2005. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell. Biol. 17: 631-636.
25. Pap M, Cooper GM. 1998. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273: 19929-19932.
26. Precht TA, Phelps RA, Linseman DA, Butts BD, Le SS, Laessig TA, Bouchard RJ, Heidenreich KA. 2005. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ. 12: 255-265.
27. Sharpe JC, Arnoult D, Youle RJ. 2004. Control of mitochondrial permeability by Bcl-2 family members. Biochim. Biophys. Acta 1644: 107-113.
28. Simeonova PP, Luster MI. 2004. Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol. 198: 444-449.
29. Song L, De Sarno P, Jope RS. 2002. Central role of glycogen synthase kinase-3β in endoplasmic reticulum stress-induced caspase-3 activation. J. Biol. Chem. 277: 44701-44708.
30. Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
31. Wang X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933.
32. Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS. 2003. Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53. J. Biol. Chem. 278: 48872-48879.
33. Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS. 2002. Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage. Proc. Natl Acad. Sci. USA 99: 7951-7955.
34. 3) induces apoptosis through activation of Bax in hematopoietic cells. Oncogene 24: 3339-3347.